By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Repligen Corporation 

41 Seyon Street, Building #1, Suite 100

Waltham  Massachusetts  02495  U.S.A.
Phone: 781-250-0111 Fax: 781-250-0115



Company News
Repligen Corporation (RGEN) Reports Second Quarter 2014 Financial Results 8/11/2014 7:42:05 AM
Repligen Corporation (RGEN) To Report Second Quarter 2014 Financial Results 7/28/2014 7:44:56 AM
Repligen Corporation (RGEN) Hires Jon K. Snodgres As Chief Financial Officer 7/15/2014 6:24:04 AM
Repligen Corporation (RGEN) Scoops Up Small New Jersey Firm Refine Technology For $24.5 Million Cash/Stock Deal 6/4/2014 7:22:35 AM
Tosoh Bioscience, Inc. Introduces OPUS® Pre-Packed Chromatography Columns From Repligen Corporation (RGEN) 3/3/2014 10:18:12 AM
Repligen Corporation (RGEN), Continuing Overhaul, Flips Rare Disease Drugs To BioMarin Pharmaceutical Inc. (BMRN) In Deal Worth $162 Million 1/21/2014 8:15:41 AM
Repligen Corporation (RGEN) Reports Third Quarter 2013 Financial Results 11/7/2013 9:38:29 AM
Repligen Corporation (RGEN) to Present at the 2013 Stephens Fall Investment Conference 11/6/2013 9:29:23 AM
Repligen Corporation (RGEN) Completes Expansion of U.S. Manufacturing Facility 11/1/2013 9:22:34 AM
Repligen Corporation (RGEN) Receives First Milestone Payment From Pfizer Inc. (PFE) Under Licensing Agreement for Spinal Muscular Atrophy Program 9/4/2013 10:08:28 AM